SCHEMBL12251

SCHEMBL12251

C[C@H]1CCCN(C(=O)CC2CCOCC2)C1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.58
▸ LMNA P02545 2/20 0.58
▸ MEN1 O00255 3/20 0.54
▸ KMT2A Q03164 3/20 0.54
▸ POLB P06746 1/20 0.54
▸ MAPT P10636 1/20 0.54
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ HPGD P15428 3/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ GAA P10253 2/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ RAB9A P51151 4/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.42
▸ RECQL P46063 1/20 0.41
▸ PRNP P04156 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ LRRK2 Q5S007 1/20 0.41
▸ NAMPT P43490 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12256 1.00 ALDH1A1 (0.58) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL19913941 0.91 ALDH1A1 (0.45) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL12970 0.91 ALDH1A1 (0.45) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL12449702 0.91 ALDH1A1 (0.45) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL15014491 0.89 ALDH1A1 (0.67) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL19864779 0.89 ALDH1A1 (0.67) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL12449650 0.86 ALDH1A1 (0.63) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL13018 0.86 ALDH1A1 (0.63) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL18082558 0.84 ALDH1A1 (0.41) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL19864581 0.83 ALDH1A1 (0.59) ALDH1A1LMNAMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9073940-B2 Tricyclic pyrazol amine derivatives MERCK SERONO SA (CH) 2015-07-07 — — US disclosed
US-9073940-B2 Tricyclic pyrazol amine derivatives MERCK SERONO SA (CH) 2015-07-07 — — US disclosed
US-20120238545-A1 TRICYCLIC PYRAZOL AMINE DERIVATIVES MERCK SERONO SA (CH) 2012-09-20 — — US disclosed
US-20120238545-A1 TRICYCLIC PYRAZOL AMINE DERIVATIVES MERCK SERONO SA (CH) 2012-09-20 — — US disclosed
WO-2011058149-A1 TRICYCLIC PYRAZOL AMINE DERIVATIVES MERCK SERONO S.A. (CH) 2011-05-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120238545-A1 TRICYCLIC PYRAZOL AMINE DERIVATIVES PI4KB, MTOR, PI4KA ALDH1A1 3185/4885LMNA 4520/4885MEN1 1024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback